Forbes November 22, 2022
Healthcare is very complex but very much interconnected. In my last column, I discussed why it is imperative that pharmaceutical companies overhaul their research and development (R&D) approach, and how failure to do so will lead to serious, unintended consequences for cancer patients in desperate search of and need for life-saving drugs. While tightening legislative and regulatory pressures are major contributors to this serious predicament, there is also trouble brewing upstream.
For those living with chronic conditions, a fractured U.S. healthcare delivery system that prioritizes profits over patient outcomes has left them in the lurch. Given that many chronic illnesses can lead to cancer and untimely death, consumers need to understand the risks of chronic disease and what they can...
Today's Sponsors
Today's Sponsor